Skip to content

Clinical trials

Phase 1 Bacterial Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacterial Infections Phase: Phase 1 Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20091
20102
20121
20132
20141
20161
20181
20192
20201
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Qpex Biopharma, Inc.4
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)3
Bugworks Research Inc.2
Andrew Steer1
Arixa Pharmaceuticals1
AtoGen Co. Ltd1
Meiji Seika Pharma Co., Ltd.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacterial Infections21
Communicable Diseases2
Gram-Negative Bacterial Infections1
Gram-Positive Bacterial Infections1
Respiratory Tract Infections1
Staphylococcal Infections1
Staphylococcal Skin Infections1
Streptococcal Infections1
Vaginal Diseases1
Vaginitis1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.